-+ 0.00%
-+ 0.00%
-+ 0.00%

Benitec Biopharma Q3 EPS $(0.24) Beats $(0.35) Estimate

Benzinga·05/14/2025 12:13:51
Listen to the news
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.35) by 31.43 percent. This is a 85.37 percent increase over losses of $(1.64) per share from the same period last year.